Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries

被引:264
作者
Janssen, Mathieu F. [1 ]
Bonsel, Gouke J. [2 ,3 ]
Luo, Nan [4 ]
机构
[1] Erasmus Univ, Dept Med Psychol & Psychotherapy, Erasmus MC, POB 2040, NL-3000 CA Rotterdam, Netherlands
[2] Erasmus Univ, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands
[3] Univ Utrecht, Div Mother & Child, UMC Utrecht, Utrecht, Netherlands
[4] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore
关键词
TRADE-OFF VALUES; HEALTH STATES; DUTCH TARIFF; BOLT-ON; EUROQOL; VALUATION; VERSION; SCORE; HIP; RESPONSIVENESS;
D O I
10.1007/s40273-018-0623-8
中图分类号
F [经济];
学科分类号
02 ;
摘要
This study describes the first empirical head-to-head comparison of EQ-5D-3L (3L) and EQ-5D-5L (5L) value sets for multiple countries. A large multinational dataset, including 3L and 5L data for eight patient groups and a student cohort, was used to compare 3L versus 5L value sets for Canada, China, England/UK (5L/3L, respectively), Japan, The Netherlands, South Korea and Spain. We used distributional analyses and two methods exploring discriminatory power: relative efficiency as assessed by the F statistic, and an area under the curve for the receiver-operating characteristics approach. Differences in outcomes were explored by separating descriptive system effects from valuation effects, and by exploring distributional location effects. In terms of distributional evenness, efficiency of scale use and the face validity of the resulting distributions, 5L was superior, leading to an increase in sensitivity and precision in health status measurement. When compared with 5L, 3L systematically overestimated health problems and consequently underestimated utilities. This led to bias, i.e. over- or underestimations of discriminatory power. We conclude that 5L provides more precise measurement at individual and group levels, both in terms of descriptive system data and utilities. The increased sensitivity and precision of 5L is likely to be generalisable to longitudinal studies, such as in intervention designs. Hence, we recommend the use of the 5L across applications, including economic evaluation, clinical and public health studies. The evaluative framework proved to be useful in assessing preference-based instruments and might be useful for future work in the development of descriptive systems or health classifications.
引用
收藏
页码:675 / 697
页数:23
相关论文
共 59 条
[1]   Comparing the EQ-5D 3L and 5L: measurement properties and association with chronic conditions and multimorbidity in the general population [J].
Agborsangaya, Calypse B. ;
Lahtinen, Markus ;
Cooke, Tim ;
Johnson, Jeffrey A. .
HEALTH AND QUALITY OF LIFE OUTCOMES, 2014, 12
[2]   EQ-5D-5L versus EQ-5D-3L: The Impact on Cost Effectiveness in the United Kingdom. [J].
Alava, Monica Hernandez ;
Wailoo, Allan ;
Grimm, Sabine ;
Pudney, Stephen ;
Gomes, Manuel ;
Sadique, Zia ;
Meads, David ;
O'Dwyer, John ;
Barton, Garry ;
Irvine, Lisa .
VALUE IN HEALTH, 2018, 21 (01) :49-56
[3]   A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states [J].
Badia, X ;
Roset, M ;
Herdman, M ;
Kind, P .
MEDICAL DECISION MAKING, 2001, 21 (01) :7-16
[4]   Canadian Valuation of EQ-5D Health States: Preliminary Value Set and Considerations for Future Valuation Studies [J].
Bansback, Nick ;
Tsuchiya, Aki ;
Brazier, John ;
Anis, Aslam .
PLOS ONE, 2012, 7 (02)
[5]  
Brooks R., 2013, The EuroQol group after 25 years
[6]   Reliability and validity of the EQ-5D-5L compared to the EQ-5D-3L in patients with osteoarthritis referred for hip and knee replacement [J].
Conner-Spady, Barbara L. ;
Marshall, Deborah A. ;
Bohm, Eric ;
Dunbar, Michael J. ;
Loucks, Lynda ;
Al Khudairy, Ammar ;
Noseworthy, Tom W. .
QUALITY OF LIFE RESEARCH, 2015, 24 (07) :1775-1784
[7]   Valuing health-related quality of life: An EQ-5D-5L value set for England [J].
Devlin, Nancy J. ;
Shah, Koonal K. ;
Feng, Yan ;
Mulhern, Brendan ;
van Hout, Ben .
HEALTH ECONOMICS, 2018, 27 (01) :7-22
[8]   EQ-5D and the EuroQol Group: Past, Present and Future [J].
Devlin, Nancy J. ;
Brooks, Richard .
APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2017, 15 (02) :127-137
[9]   Modeling valuations for EuroQol health states [J].
Dolan, P .
MEDICAL CARE, 1997, 35 (11) :1095-1108
[10]  
Fairclough DL, 2010, DESIGN AND ANALYSIS OF QUALITY OF LIFE STUDIES IN CLINICAL TRIALS, SECOND EDITION, P1, DOI 10.1201/9781420061185